structural-heart

Genesis Medtech — independent third-party profile of a public API surface, by API Evangelist. Genesis MedTech is a global medical device company founded in Singapore in 2019, building and commercializing advanced clinical solutions across surgical, vascular intervention, and structural heart categories.

Evalve — independent third-party profile of a public API surface, by API Evangelist. Evalve, Inc. was a medical-device company that pioneered percutaneous (catheter-based) mitral valve repair with its MitraClip system for treating mitral regurgitation. It was acquired by Abbott Laboratories in 2009 (~$410M) and folded into Abbott Structural Heart /

venusmedtech — independent third-party profile of a public API surface, by API Evangelist. Venus Medtech (Hangzhou) Inc. is a China-based innovator in transcatheter structural heart valve therapies, founded in 2009 and headquartered in Hangzhou. Listed on the Hong Kong Stock Exchange (2500.HK), it pioneered first-in-China TAVR and TPVR solutions an

Capstan Medical — independent third-party profile of a public API surface, by API Evangelist. Capstan Medical is a Santa Cruz, California medical device company founded in 2020 out of the Occam Labs incubator by Dan Wallace, with Maggie Nixon as CEO. The company is developing a surgical robotics platform for structural heart disease, merging roboti